You just read:

Compugen Announces Clinical Milestone Payment in Cancer Immunotherapy Collaboration With Bayer Following Dosing of First Patient in BAY 1905254 Phase 1 Trial

News provided by

Compugen Ltd.

Sep 20, 2018, 07:00 ET